Hepatitis C, HIV, and Injection-Related Infections: A Family Guide

Most families worry about overdose, and they should. But there is a second risk that develops quietly alongside drug use — one that often shows up years later, in a liver clinic or a hospital bed, long after the injections that caused it have stopped.

Hepatitis C, hepatitis B, and HIV spread through blood and through the shared equipment used to inject drugs. Unlike an overdose, these infections announce nothing. Most people who have hepatitis C do not know they have it, because it can cause no symptoms for decades while it slowly scars the liver.

The reason this guide exists is that all three of these infections are now either curable, treatable, or preventable. That is not optimism; it is the current state of medicine. Hepatitis C can be cured in most people in 8 to 12 weeks with oral medication. HIV can be prevented before exposure with a prescription, and it can be controlled with treatment if it is caught. Hepatitis B has a vaccine.

What families need is not fear. It is information that arrives before the damage does.

Why infections and addiction travel together

Viral hepatitis is inflammation of the liver. It can be caused by toxins such as alcohol and drugs, by autoimmune conditions, or by viruses — labeled A, B, C, D, and E. The two most likely to be transmitted through drug use are hepatitis B and hepatitis C, particularly among people who inject drugs.

Two facts explain why this is so common:

The equipment, not just the needle. Infection spreads through blood. That includes syringes, but also the cookers, cotton filters, water, and rinse cups that get passed around a group. Shared preparation equipment carries blood even when a person believes they had a "clean" needle.
Frequency beats intention. Someone who injects daily may make one rushed, unplanned decision hundreds of times a year. Because drug use impairs judgment, the same unsafe choice tends to repeat, and transmission follows.

The numbers give scale. An estimated 2.4 million Americans are living with hepatitis C, with roughly 44,700 new acute cases reported in 2017 — and new acute infections have risen sharply in the United States since 2010, most often linked to injection drug use. An estimated 862,000 people are living with chronic hepatitis B.

Transmission can be fast. One study cited by NIDA found that a single person who injects drugs and is infected with hepatitis C is likely to infect about 20 others, with much of that spread happening within the first three years of the original infection. This is why hepatitis C moves through a community in clusters rather than one case at a time — and why it is worth interrupting, even if your family member is not ready to stop using.

There is one more layer that families should understand. Drug and alcohol use can also damage the liver directly, which means a person who is infected and continues to drink or use faces a higher risk of chronic liver disease and liver cancer. Liver injury from substances and liver injury from a virus add together.

Hepatitis C: the infection most people don't know they have

Hepatitis C is the one families most often discover by accident, during routine bloodwork for something else.

How it spreads — and how it does not

Hepatitis C spreads through blood-to-blood contact. In the context of drug use, that means shared syringes and shared injection equipment. It is not spread by hugging, kissing, sharing food or utensils, coughing, or sitting in the same room. Family members living with someone who has hepatitis C are not at risk from ordinary household contact. This matters, because much of the stigma around the diagnosis is based on a fear of transmission that is not real.

What it does if it is not treated

Roughly three out of four people living with hepatitis C are baby boomers, born between 1945 and 1965, but the fastest-growing group of new infections is younger people who inject drugs. Left untreated, hepatitis C can progress to cirrhosis — a progressive scarring and malfunctioning of the liver — and to a type of liver cancer called hepatocellular carcinoma. Hepatitis B and C together are linked to about 65 percent of liver cancers worldwide, with nearly half of those cases caused by hepatitis C alone.

The scale is sobering: since 2012, more deaths in the United States have been attributed to hepatitis C than to all 60 other reportable infectious diseases combined.

The good news is genuinely good

Modern antiviral treatment cures more than 90 percent of people with hepatitis C who take it, usually over 8 to 12 weeks of oral medication. Cure dramatically reduces the risk of death, cirrhosis, and liver cancer. The U.S. Preventive Services Task Force notes that treatment typically consists of these oral direct-acting antiviral regimens, and hepatitis C specialists now describe cure rather than management as the realistic goal.

Two practical points families should hold onto:

Treatment is compatible with addiction treatment. NIDA reports that patients with hepatitis who are receiving medication for opioid use disorder can be safely treated with antiviral medications. A person does not have to be "clean" to be cured of hepatitis C.
Reinfection is possible after cure. Cure is not a vaccine. If risky injection continues, the protection has to come from harm reduction, not from the fact of having been treated.

Hepatitis B: the one with a vaccine

Hepatitis B behaves similarly to hepatitis C but with one important difference: it is preventable. Hepatitis B spreads through blood and other bodily fluids, and it is transmitted through shared injection equipment as well as through sexual contact.

Chronic hepatitis B does not go away on its own in most people. It is managed rather than cured, with antiviral drugs and consistent medical monitoring to confirm the medication is keeping the virus suppressed and the liver is not progressing toward damage or cancer.

Hepatitis B vaccination is recommended for people who inject drugs, and it is one of the services that syringe services programs routinely offer alongside testing. If your family member does not know whether they were vaccinated, that question belongs on the list for their next medical visit. The vaccine is also available to household members and partners.

HIV: prevention has changed completely

Of the three infections here, HIV is the one where the prevention landscape has changed the most — and where outdated fear does the most harm. The HIV epidemic and the overdose crisis are closely intertwined: people who use drugs face higher HIV risk from shared injection equipment and from the way drug use can shape sexual risk, and they often face extra barriers to the tools that prevent, diagnose, and treat HIV.

PrEP: prevention for someone who does not have HIV

PrEP (pre-exposure prophylaxis) is medicine — a daily pill or a periodic injection — for adults and adolescents who do not have HIV but may be exposed to it through sex or injection drug use. It is one of the most important things a family can bring up, because so few people know it applies to injection drug use.

A person may be a candidate for PrEP if they inject drugs and:

Have an injection partner who has HIV, or
Share needles, syringes, or other injection equipment such as cookers.

For protection against HIV through injection drug use, PrEP pills reach maximum protection at about 21 days of daily use — so starting early matters more than starting perfectly.

Cost is usually the first objection, and here the answer is straightforward: most insurance plans and state Medicaid programs cover some form of PrEP, and under the Affordable Care Act, PrEP must be free under almost all health insurance plans — no charge for the medication, the clinic visits, or the lab tests needed to maintain the prescription. For people without insurance, manufacturers and some states run assistance programs that cover medication, clinic visits, or both.

PrEP requires an HIV test before starting, and routine follow-up visits and HIV tests afterward. It prevents HIV, but not other sexually transmitted infections or pregnancy. And it must be taken as prescribed — the medicine only blocks the virus when enough of it is in the bloodstream.

PEP: prevention after a possible exposure

If someone may have been exposed to HIV — a shared syringe, a needlestick, condomless sex — there is a short course of medication called PEP (post-exposure prophylaxis) that can prevent infection. It needs to be started as soon as possible and no later than 72 hours after the exposure. This is an emergency-room or urgent-care conversation, not a wait-and-see one.

If the test comes back positive

HIV is no longer what it was in 1990. Modern treatment suppresses the virus to undetectable levels, a point at which HIV is not transmitted through sex — which means treatment protects both the person taking it and the people around them. The goal is to get someone into care quickly, not to treat a diagnosis as an ending.

Skin and bloodstream infections: the ones families see first

The infections families are most likely to notice are the ones that happen at or near the injection site, and the ones that travel into the bloodstream.

Abscesses and cellulitis. Localized infections around an injection site can become deep, painful, and dangerous if they spread. A hot, swollen, rapidly enlarging area, or one with streaks, needs medical evaluation the same day — not squeezing at home.
Bloodstream infections and endocarditis. Bacteria introduced through injection can infect the blood and, in the most serious cases, the heart valves — a condition called endocarditis that requires intravenous antibiotics and sometimes surgery. CDC lists preventing endocarditis and other infections as a core goal of syringe services programs. Fever with chills, unexplained fatigue, a new murmur, or shortness of breath in someone who injects drugs warrants urgent care.

A practical tip for the emergency room: encourage honesty about injection drug use. It changes what the clinical team suspects, what tests they run, and how they manage pain. Fear of being judged or of legal consequences is the main reason this information is withheld, and withholding it is what turns a treatable infection into a missed one.

What actually reduces the risk

Syringe services programs

Syringe services programs are community-based public health programs that provide sterile syringes and safe disposal of used equipment, testing and vaccination for infectious diseases, and linkage to treatment — both for infections and for substance use disorder itself.

The evidence is not ambiguous. CDC reports that syringe services programs are associated with an estimated 50 percent reduction in HIV and hepatitis C incidence, and that nearly 30 years of research shows comprehensive programs are safe, effective, and cost-saving. They do not increase illegal drug use or crime.

Supporting this can feel like accepting drug use. It is not. It is accepting a fact that the parents of a teenager with diabetes already understand: providing clean equipment does not cause the disease. It prevents a second diagnosis on top of the first.

If a program is not an option

Harm reduction works in steps. If your family member will not go to a syringe services program, these reduce risk to a meaningful degree:

A new, sterile syringe for every injection — with the understanding that a "new" syringe is one nobody else has used.
Never sharing cookers, cotton, filters, rinse water, or water containers.
Washing hands and cleaning the skin at the injection site.
Keeping a personal, separate kit so equipment does not circulate through a group.
Never using alone, and keeping naloxone in the house.

Testing on a schedule, not once

Because these infections are silent, testing is the intervention.

CDC recommends that people who inject drugs be tested for hepatitis B and hepatitis C as part of routine medical care.
The U.S. Preventive Services Task Force recommends screening all adults aged 18 to 79 at least once, and periodic screening for people with continued risk, including past or current injection drug use.
Screening begins with an antibody test. A positive antibody result means exposure and must be followed by a viral-load test to see whether the infection is still active. Anyone with a confirmed infection should be connected to a clinician who specializes in viral hepatitis treatment.
Antibody tests can take weeks to months to turn positive after an exposure. A viral-load (RNA) test can detect infection earlier. If a first test is negative but the exposure was recent, it should be repeated.

Free or low-cost testing is available through local health departments, community clinics, syringe services programs, and the CDC's GetTested locator (gettested.cdc.gov), which searches HIV, STI, and hepatitis testing near a ZIP code.

Medication for opioid use disorder is prevention

Buprenorphine, methadone, and naltrexone do more than reduce cravings and overdose risk. By reducing the frequency of injection, they reduce exposure to every infection described in this guide. NIDA notes that substance use disorder treatment is critical for people who inject drugs specifically because it reduces the behaviors that transmit hepatitis — and that treatment can run safely alongside antiviral therapy.

That is the argument to make to a family member who is not ready to stop using, but is willing to consider medication: it lowers the odds of everything on this page at once.

Talking about it without shame

The instinct to lead with consequences usually backfires. A few approaches that tend to work better:

Separate the person from the behavior. "I want you to be healthy" lands differently than "look what you're doing to yourself."
Make one small ask. Not "get tested and get treatment and get clean." Instead: "Will you get a hepatitis C test with me this week? I'll drive."
Offer logistics, not lectures. A ride, a co-pay, a phone call to a clinic. Barriers are usually practical, not motivational.
Expect the answer to be no the first time. The ask is not wasted. It plants a door.
Do not use a diagnosis as leverage. Shame increases secrecy, and secrecy increases risk.

If your loved one is in treatment or newly in recovery

Early recovery is actually an ideal window for this work, because people are already in contact with medical care.

Ask the treatment program what screening they run, and what happens to the results.
Confirm hepatitis A and B vaccination status.
If hepatitis C is confirmed, ask when antiviral treatment can start. It usually does not need to wait for anything else.
Get an HIV test and ask about PrEP if risk continues.
Watch for the infections that lag: fatigue, jaundice (yellowing of the eyes or skin), dark urine, or abdominal swelling are reasons to get seen promptly.
Repeat testing if there was a recent exposure, and again if injection continues.

Paying for testing and treatment

Cost is a real barrier, and it is also the most solvable one on this list.

Preventive coverage. Under the Affordable Care Act, PrEP must be covered at no cost under almost all health plans, including the clinic visits and lab tests needed to maintain it. Many plans cover hepatitis screening as preventive care as well.
Medicaid and Medicare. Both cover hepatitis C treatment and HIV care; Medicaid expansion states cover far more adults. If a person is uninsured but eligible, enrollment is often the fastest route to treatment.
HIV-specific programs. The Ryan White HIV/AIDS Program and state AIDS Drug Assistance Programs help cover HIV care and medication for people without adequate coverage.
Uninsured and underinsured. Federally qualified health centers charge on a sliding scale, local health departments often provide free hepatitis and HIV testing, and syringe services programs connect people to treatment regardless of insurance.
Manufacturer assistance. Drugmakers run patient assistance programs for hepatitis C and HIV medications, as well as for PrEP.

Where to get help right now

988 Suicide & Crisis Lifeline — call or text 988, 24/7, for any mental health or substance use crisis, including for families.
SAMHSA National Helpline — 1-800-662-4357 — free, confidential, 24/7 treatment referral for substance use and mental health, in English and Spanish.
findtreatment.gov — SAMHSA's treatment locator, searchable by ZIP code and payment type.
gettested.cdc.gov — CDC's free, confidential HIV, STI, and hepatitis testing locator.
Poison Control — 1-800-222-1222 — 24/7 for exposure questions.
911 — for an overdose, a fever with chills in someone who injects drugs, chest pain, confusion, or any emergency. Good Samaritan laws in most states protect people who call for help during an overdose.

Key takeaways

Sharing injection equipment — not just needles — transmits hepatitis C, hepatitis B, and HIV. Cookers, cottons, water, and rinse cups carry blood too.
These infections are silent for years. Testing is the intervention, and CDC recommends hepatitis B and C testing for people who inject drugs as part of routine care.
Hepatitis C is curable in more than 90 percent of cases with 8 to 12 weeks of oral medication, and treatment can run alongside medication for opioid use disorder.
Hepatitis B is preventable with a vaccine. HIV is preventable before exposure with PrEP — including for people who inject drugs — and treatable if detected.
Syringe services programs are associated with roughly a 50 percent reduction in HIV and hepatitis C incidence and do not increase drug use or crime.
Abscesses, bloodstream infections, and endocarditis are the complications families see first. Fever with chills, a spreading hot swollen area, or new shortness of breath means urgent care, not waiting.
Medication for opioid use disorder reduces injection frequency, which reduces exposure to every infection here.